Better than CAR-T? Already prepping for a US launch, MorphoSys posts stellar DLBCL data to field against Novartis, Gilead

Better than CAR-T? Already prepping for a US launch, MorphoSys posts stellar DLBCL data to field against Novartis, Gilead

Source: 
Endpoints
snippet: 

Already beavering away at building a US commercial operation, MorphoSys {$MOR} is now bearing down on Novartis and Gilead with a potential CAR-T killer soon to be put into the hands of US regulators.